(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDP1 mRNA] CTD PMID:31150632 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731545 6480464 Tetrachlorodibenzodioxin results in increased expression of PDP1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PDP1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618761 6480464 Tetrachlorodibenzodioxin affects the expression of PDP1 mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PDP1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:731545 6480464 Lactic Acid results in increased expression of PDP1 mRNA CTD PMID:30851411 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PDP1 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PDP1 mRNA CTD PMID:31881176 aldehydo-D-glucose multiple interactions EXP 6480464 [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein CTD PMID:20181797 all-trans-retinoic acid decreases expression ISO RGD:731545 6480464 Tretinoin results in decreased expression of PDP1 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PDP1 mRNA CTD PMID:16483693 aripiprazole increases expression EXP 6480464 Aripiprazole results in increased expression of PDP1 mRNA CTD PMID:17868501 aristolochic acid A decreases expression ISO RGD:731545 6480464 aristolochic acid I results in decreased expression of PDP1 mRNA CTD PMID:33212167 atrazine decreases expression ISO RGD:731545 6480464 Atrazine results in decreased expression of PDP1 mRNA CTD PMID:22378314 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA CTD PMID:33854195 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PDP1 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:731545 6480464 Benzo(a)pyrene affects the methylation of PDP1 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:731545 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:731545 6480464 7 more ... CTD PMID:20018196 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PDP1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:731545 6480464 bisphenol A results in decreased expression of PDP1 protein CTD PMID:33376534 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PDP1 gene CTD PMID:28505145 butanal increases expression ISO RGD:731545 6480464 butyraldehyde results in increased expression of PDP1 mRNA CTD PMID:26079696 calcitriol decreases expression ISO RGD:731545 6480464 Calcitriol results in decreased expression of PDP1 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:731545 6480464 Carbamazepine affects the expression of PDP1 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1618761 6480464 Nanotubes, Carbon affects the expression of PDP1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1618761 6480464 Nanotubes, Carbon results in increased expression of PDP1 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1618761 6480464 Nanotubes, Carbon analog results in decreased expression of PDP1 mRNA CTD PMID:25554681 celastrol increases expression ISO RGD:1618761 6480464 celastrol results in increased expression of PDP1 mRNA, celastrol results in increased expression of PDP1 protein CTD PMID:35679966 celastrol multiple interactions ISO RGD:1618761 6480464 celastrol inhibits the reaction [Dietary Fats results in decreased expression of PDP1 mRNA], celastrol inhibits the reaction [Dietary Fats results in decreased expression of PDP1 protein] CTD PMID:35679966 CGP 52608 multiple interactions ISO RGD:731545 6480464 CGP 52608 promotes the reaction [RORA protein binds to PDP1 gene] CTD PMID:28238834 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA CTD PMID:33854195 choline multiple interactions ISO RGD:1618761 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDP1 mRNA CTD PMID:20938992 cocaine increases expression EXP 6480464 Cocaine results in increased expression of PDP1 mRNA CTD PMID:27899881 copper atom multiple interactions ISO RGD:731545 6480464 [NSC 689534 binds to Copper] which results in increased expression of PDP1 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of PDP1 mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RGD:731545 6480464 [NSC 689534 binds to Copper] which results in increased expression of PDP1 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of PDP1 mRNA CTD PMID:22465980 copper(II) sulfate increases expression ISO RGD:731545 6480464 Copper Sulfate results in increased expression of PDP1 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:731545 6480464 Coumestrol results in decreased expression of PDP1 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:731545 6480464 Asbestos, Crocidolite results in increased expression of PDP1 mRNA CTD PMID:18687144 cyclosporin A decreases expression ISO RGD:731545 6480464 Cyclosporine results in decreased expression of PDP1 mRNA CTD PMID:22147139 cyclosporin A increases expression ISO RGD:731545 6480464 Cyclosporine results in increased expression of PDP1 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose multiple interactions EXP 6480464 [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein CTD PMID:20181797 dexamethasone multiple interactions EXP 6480464 [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein more ... CTD PMID:20181797 dexamethasone increases expression ISO RGD:1618761 6480464 Dexamethasone results in increased expression of PDP1 mRNA CTD PMID:22733784 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PDP1 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:731545 6480464 dicrotophos results in decreased expression of PDP1 mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PDP1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:731545 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDP1 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1618761 6480464 Ethanol results in increased expression of PDP1 mRNA CTD PMID:30319688 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PDP1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1618761 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDP1 mRNA CTD PMID:20938992 glucose multiple interactions EXP 6480464 [Dexamethasone results in decreased oxidation of Glucose] which results in increased phosphorylation of and results in decreased activity of PDP1 protein CTD PMID:20181797 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA CTD PMID:33854195 hydrogen peroxide increases expression ISO RGD:731545 6480464 Hydrogen Peroxide results in increased expression of PDP1 mRNA CTD PMID:18951874 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA CTD PMID:33854195 indometacin decreases expression ISO RGD:731545 6480464 Indomethacin results in decreased expression of PDP1 mRNA CTD PMID:16984733 L-methionine multiple interactions ISO RGD:1618761 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDP1 mRNA CTD PMID:20938992 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PDP1 mRNA CTD PMID:19564919 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of PDP1 mRNA CTD PMID:16393664 methylmercury chloride increases expression ISO RGD:731545 6480464 methylmercuric chloride results in increased expression of PDP1 mRNA CTD PMID:28001369 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of PDP1 mRNA CTD PMID:29162477 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PDP1 gene CTD PMID:33148267 N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of PDP1 mRNA CTD PMID:15954086 N-nitrosodiethylamine increases expression ISO RGD:1618761 6480464 Diethylnitrosamine results in increased expression of PDP1 mRNA CTD PMID:24535843 nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Dexamethasone results in increased phosphorylation of PDP1 protein] CTD PMID:20181797 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PDP1 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1618761 6480464 Acetaminophen affects the expression of PDP1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PDP1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:731545 6480464 Acetaminophen results in increased expression of PDP1 mRNA CTD PMID:25704631 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PDP1 mRNA CTD PMID:19162173 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of PDP1 gene CTD PMID:33148267 potassium dichromate decreases expression ISO RGD:1618761 6480464 Potassium Dichromate results in decreased expression of PDP1 mRNA CTD PMID:23608068 progesterone decreases expression ISO RGD:731545 6480464 Progesterone results in decreased expression of PDP1 mRNA CTD PMID:18037150 propanal increases expression ISO RGD:731545 6480464 propionaldehyde results in increased expression of PDP1 mRNA CTD PMID:26079696 quercetin affects expression ISO RGD:731545 6480464 Quercetin affects the expression of PDP1 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:731545 6480464 Lactic Acid results in increased expression of PDP1 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:731545 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of PDP1 mRNA CTD PMID:19059307 SB 431542 multiple interactions ISO RGD:731545 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDP1 mRNA CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:731545 6480464 Asbestos, Serpentine results in increased expression of PDP1 mRNA CTD PMID:29523930 silver atom decreases expression ISO RGD:1618761 6480464 Silver results in decreased expression of PDP1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1618761 6480464 Silver results in decreased expression of PDP1 mRNA CTD PMID:27131904 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of PDP1 mRNA CTD PMID:25993096 tamoxifen multiple interactions ISO RGD:731545 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of PDP1 mRNA CTD PMID:19059307 tert-butyl hydroperoxide increases expression ISO RGD:731545 6480464 tert-Butylhydroperoxide results in increased expression of PDP1 mRNA CTD PMID:15336504 testosterone enanthate affects expression ISO RGD:731545 6480464 testosterone enanthate affects the expression of PDP1 mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO RGD:1618761 6480464 Carbon Tetrachloride affects the expression of PDP1 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PDP1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PDP1 mRNA] CTD PMID:31150632 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA CTD PMID:33854195 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PDP1 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PDP1 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:731545 6480464 torcetrapib results in increased expression of PDP1 mRNA CTD PMID:23228038 trichostatin A decreases expression ISO RGD:731545 6480464 trichostatin A results in decreased expression of PDP1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:731545 6480464 trichostatin A affects the expression of PDP1 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:731545 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDP1 mRNA CTD PMID:27188386 urethane increases expression ISO RGD:731545 6480464 Urethane results in increased expression of PDP1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:731545 6480464 Valproic Acid results in decreased methylation of PDP1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:731545 6480464 Valproic Acid results in increased expression of PDP1 mRNA CTD PMID:28001369 valproic acid affects expression ISO RGD:731545 6480464 Valproic Acid affects the expression of PDP1 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PDP1 mRNA CTD PMID:23034163 zinc atom increases expression EXP 6480464 Zinc results in increased expression of PDP1 mRNA CTD PMID:17074742 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of PDP1 mRNA CTD PMID:17074742 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of PDP1 mRNA CTD PMID:17074742
